SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZTC -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (722)11/9/2000 6:56:47 AM
From: Micawber  Read Replies (1) | Respond to of 752
 
Warburg Dillon Read Views 11/8/2000 2:21:13 PM:

GZTC - reiterated strong buy. Rights for recombinant ATII reacquired. Discussions with potential new development partners, decision based on (GENZ) pending acquisition of (GELX). Additional studies for rhATIII expected.

Talk about seeing a silver lining...



To: Biomaven who wrote (722)11/9/2000 4:07:42 PM
From: nigel bates  Read Replies (1) | Respond to of 752
 
Nice call.

nig